Risk‐Reducing Gender‐Affirming Mastectomy: Unique Considerations in <scp>BRCA</scp>
Individualized breast cancer risk assessment should be considered for transmasculine patients pursuing gender-affirming mastectomy to identify and educate high-risk patients about the option for risk-reduction gender-affirming mastectomy. This reduces oncologic risk while achieving the desired cosmetic outcome, ultimately enhancing preventative care provided to an underserved population.
Authors
- Aladdin H. Hassanein (ORCID: https://orcid.org/0000-0002-0966-7851)
- Ivan Hadad (ORCID: https://orcid.org/0009-0000-0832-5537)
- Bailey Johnson
- Carla Suzanne Fisher
Institutions
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1002/ccr3.70336
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00